Skip directly to site content Skip directly to page options Skip directly to A-Z link Skip directly to A-Z link Skip directly to A-Z link

Disclaimer: Early release articles are not considered as final versions. Any changes will be reflected in the online version in the month the article is officially released.

Volume 31, Number 1—January 2025
CME ACTIVITY - Synopsis

Pneumococcal Septic Arthritis among Adults, France, 2010–2018

Farida HamdadComments to Author , Nadim El Bayeh, Gabriel Auger, Olivia Peuchant, Frédéric Wallet, Raymond Ruimy, Florence Reibel, Christian Martin, Marie-Cécile Ploy, Frédéric Robin, Chrislène Laurens, Philippe Lanotte, Marie Kempf, Jennifer Tetu, Hélène Revillet, Isabelle Patry, Philippe Cailloux, Mélissa Azouaou, Emmanuelle Varon, Pierre Duhaut, Alain Lozniewski, and Vincent Cattoir
Author affiliation: Université de Picardie Jules Verne, Amiens, France (F. Hamdad, N. El Bayeh, P. Duhaut); Centre Hospitalier Universitaire de Brabois-Nancy, Nancy, France (F. Hamdad, P. Cailloux, A. Lozniewski); Centre Hospitalier Universitaire Amiens-Picardie, Amiens (N. El Bayeh, P. Duhaut); Centre Hospitalier Universitaire CHU de Rennes, Rennes, France (G. Auger, V. Cattoir); Centre Hospitalier Universitaire de Bordeaux, Bordeaux, France (O. Peuchant); Centre Hospitalier Universitaire de Lille, Lille, France (F. Wallet); Centre Hospitalier Universitaire de Nice, Nice, France (R. Ruimy); Centre Hospitalier Universitaire Henri Mondor, Créteil, France (F. Reibel); Centre Hospitalier Universitaire de Limoges, Limoges, France (C. Martin, M.C. Ploy); Centre Hospitalier Universitaire de Clermont Ferrand, Clermont Ferrand, France (F. Robin); Centre Hospitalier Universitaire de Montpellier, Montpellier, France (C. Laurens); Centre Hospitalier Universitaire de Tours, Tours, France (P. Lanotte); Centre Hospitalier Universitaire d’Angers, Angers, France (M. Kempf); Centre Hospitalier Universitaire de Dijon, Dijon, France (J. Tetu); Centre Hospitalier Universitaire de Toulouse, Toulouse, France (H. Revillet); Centre Hospitalier Universitaire de Besançon, Besançon, France (I. Patry); Centre Hospitalier Intercommunal de Créteil, Créteil, France (M. Azouaou, E. Varon)

Main Article

Table 1

National health authority guidelines on pneumococcal vaccination for adults at risk for pneumococcal disease, France

Characteristic
2017 guidelines
2023 guidelines
Age ≥65 y No recommendation
No recommendation
Alcohol use
Active smoking
Immunocompromised patients: asplenia or hyposplenia, hereditary immune deficiency, HIV infection, solid organ transplant, hematopoietic stem cell, chronic autoimmune or inflammatory disease treated by immunosuppressive or biological drugs, nephrotic syndrome, or patients treated by chemotherapy for a solid tumor or hematologic malignancy 1 dose of PCV13
+
8 weeks later: 1 dose of PPV23
+
5 years later: 1 dose of PPV23
1 dose of PCV20


Patients with chronic diseases: chronic respiratory disease, severe asthma, heart failure or cyanotic heart disease, renal failure, chronic liver disease, diabetes mellitus, osteomeningeal breach, or cochlear implant

*PCV13,13-valent pneumococcal conjugate vaccine; PCV20, 20-valent pneumococcal conjugate vaccine; PPV23, 23-valent pneumococcal polysaccharide vaccine.

Main Article

Page created: December 02, 2024
Page updated: December 19, 2024
Page reviewed: December 19, 2024
The conclusions, findings, and opinions expressed by authors contributing to this journal do not necessarily reflect the official position of the U.S. Department of Health and Human Services, the Public Health Service, the Centers for Disease Control and Prevention, or the authors' affiliated institutions. Use of trade names is for identification only and does not imply endorsement by any of the groups named above.
file_external